Pierre Marc Bouloux

Affiliations: 
University College London, London, United Kingdom 
Google:
"Pierre Bouloux"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Boehm U, Bouloux PM, Dattani MT, et al. (2015) Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nature Reviews. Endocrinology. 11: 547-64
Cariboni A, André V, Chauvet S, et al. (2015) Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome. The Journal of Clinical Investigation. 125: 2413-28
Tzoulis P, Bouloux PM. (2015) Inpatient hyponatraemia: adequacy of investigation and prevalence of endocrine causes. Clinical Medicine (London, England). 15: 20-4
Jayakody SA, Andoniadou CL, Gaston-Massuet C, et al. (2012) SOX2 regulates the hypothalamic-pituitary axis at multiple levels. The Journal of Clinical Investigation. 122: 3635-46
Kim S-, Hu Y, Cadman S, et al. (2007) Diversity in fibroblast growth factor receptor 1 regulation: Learning from the investigation of Kallmann syndrome Journal of Neuroendocrinology. 20: 141-163
Pitteloud N, Meysing A, Quinton R, et al. (2006) Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Molecular and Cellular Endocrinology. 254: 60-9
Turton JP, Mehta A, Raza J, et al. (2005) Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clinical Endocrinology. 63: 10-8
Bouloux P. (2005) Testim 1% testosterone gel for the treatment of male hypogonadism. Clinical Therapeutics. 27: 286-298
González-Martínez D, Hu Y, Bouloux PM. (2004) Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Frontiers in Neuroendocrinology. 25: 108-30
Bouloux P, Warne DW, Loumaye E. (2002) Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism Fertility and Sterility. 77: 270-273
See more...